Remove companies abiomed-inc
article thumbnail

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

Benzinga

Tuesday, Shockwave Medical Inc (NASDAQ: SWAV ) shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson (NYSE: JNJ ) is reportedly in talks to acquire the company. In 2022, Johnson & Johnson acquired heart failure device-focused Abiomed Inc. for an upfront payment of $380.00

article thumbnail

Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical

Benzinga

Friday, Johnson & Johnson (NYSE: JNJ ) agreed to acquire Shockwave Medical Inc (NASDAQ: SWAV ) for $335.00 The acquisition comes a little more than a year, when in 2022, Johnson & Johnson acquired Abiomed for an upfront payment of $380.00 In November 2023, Johnson & Johnson MedTech acquired Laminar Inc.,

article thumbnail

Wachtell Lipton Discusses Mergers and Acquisitions–2022 and 2023

Reynolds Holding

A wide number of companies also announced separations, divestitures, carve-outs and spin-offs across industries over the course of the year, with over thirty $1 billion-plus divestitures and nearly forty spin-offs announced. billion acquisition of Abiomed and Amgen’s $27.8 acquisition of Biohaven Pharmaceuticals, $5.4

Finance 45